At ImmunoQs, we believe every cancer patient is unique and deserves fully personalized care and treatment. We make advanced spatial omics technologies and machine learning modeling more accessible to clinicians, scientists, and drug developers. Our digital analytics platform empowers them to make sense of highly complex and heterogeneous spatial omics data, and discover new predictive biomarkers for targeted and immunotherapy.
Our quest begins by helping scientists to design more predictive biomarker panels, perform large-scale spatial omics experiments, and quantify the spatial distributions of these markers in the tumor microenvironment.
Our digital analytics platform is user-friendly, and enables clinicians and scientists to visualize and explore large spatial omics data and discover new cues that may predict immunotherapy responses.
We work with clinicians and drug developers to test these biomarkers and machine-learning models in clinical trials, and integrate them with the current clinical workflows and patient care systems. Our goal is to improve the quality of life of patients and be cured from their diseases.